Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2007
03/29/2007US20070072809 Antiviral compounds
03/29/2007US20070072808 Antimicrobial and anticancer lipopeptides
03/29/2007US20070072807 Method of screening compounds
03/29/2007US20070072806 Inhibitor of the folding of the HIV-1-protease as antiviral agent
03/29/2007US20070072805 Fusion peptide-induced hemolysis effectively inhibited by peptides of the invention compared to virus-inhibitory peptide (VIRIP); peptide blocks cellular infection by HIV particles by interacting with the fusion peptide of HIV viral glycoprotein 41 (gp41) to prevent virus entry into thecell
03/29/2007US20070072804 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
03/29/2007US20070072803 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
03/29/2007US20070072802 Peptide nucleic acid based guanidinium compounds
03/29/2007US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2
03/29/2007US20070072800 Conjugates for cancer therapy and diagnosis
03/29/2007US20070072799 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
03/29/2007US20070072798 Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
03/29/2007US20070072797 Epitopes
03/29/2007US20070072795 Treatment of neurodegenerative disorders
03/29/2007US20070072794 Novel genes and proteins encoded thereby
03/29/2007US20070072793 Histone hyperacetylating agents for promoting wound healing and preventing scar formation
03/29/2007US20070072792 Macrocyclic lactams and pharmaceutical use thereof
03/29/2007US20070072791 Polypeptides biodrugs with given amino acid sequence which includes phosphorylated serine or threonine; Type II Diabetes and Alzheimer's Disease
03/29/2007US20070072790 Antitumor agents
03/29/2007US20070072264 Recombinant chimeric acetylcholine receptors and their derivatives recognized by cd4 t cells of myasthenic patients for the treatment of myasthenia gravis
03/29/2007US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog
03/29/2007US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof
03/29/2007US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders
03/29/2007US20070072251 In vivo imaging using peptide derivatives
03/29/2007US20070072248 Constitutively activated human G protein coupled receptors
03/29/2007US20070072244 Use of the endo-180 gene and polypeptide for diagnosis and treatment
03/29/2007US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors
03/29/2007US20070072231 Tumor suppressor gene
03/29/2007US20070072224 Diagnosis and treatment of tumor-suppressor associated disorders
03/29/2007US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis
03/29/2007US20070072177 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections
03/29/2007US20070072176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus
03/29/2007US20070071830 Method for increasing bioavailability of lipophilic bioactive compounds
03/29/2007US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein
03/29/2007US20070071824 Treatment of mucositis using N-acetylcysteine
03/29/2007US20070071806 Tansmucosal drug delivery system
03/29/2007US20070071804 Compositions and methods of preparation of liposomal microparticulate IL-12
03/29/2007US20070071779 Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof
03/29/2007US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae
03/29/2007US20070071772 reducing or inhibiting invasiveness and metastasis of tumor cells that produce globotriaosylceramide (Gb3)
03/29/2007US20070071765 Compositions for Immunotherapy and Uses Thereof
03/29/2007US20070071753 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 85 (gpr85)
03/29/2007US20070071752 Sphingosine kinase enzyme
03/29/2007US20070071749 Using cocktail comprising endothelial growth factor specific immunoglobulin and gemcitabine to treat and/or prevent pancreatic cancer
03/29/2007US20070071748 Treatment with anti-vegf antibodies
03/29/2007US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19
03/29/2007US20070071741 OCL-2A3 compositions and uses thereof
03/29/2007US20070071740 Purified amniotic membrane compositions and methods of use
03/29/2007US20070071734 ARPE-19 as platform cell line for encapsulated cell-based delivery
03/29/2007US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
03/29/2007US20070071728 Biomimetic nanocomposite
03/29/2007US20070071722 Nucleotide vaccine composition
03/29/2007US20070071721 Methods for treating viral infection using il-28 and il-29
03/29/2007US20070071720 Method of treating hepatitis B viral infection
03/29/2007US20070071719 Compositions and methods for regulation of tumor necrosis factor-alpha
03/29/2007US20070071718 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy
03/29/2007US20070071717 Treatment of B cells with IL-21 and B cell activators induces Granzyme B production
03/29/2007US20070071716 Compositions and methods for healthy pregnancy
03/29/2007US20070071714 Stem cell factor
03/29/2007US20070071712 biomimetics; cavity has affinity for glucose
03/29/2007US20070071693 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
03/29/2007US20070071690 Dry powder formulations
03/29/2007US20070071689 Advantageous combination for inhalation of nacystelyn and bronchodilators
03/29/2007US20070071677 Non-toxic membrane-translocating peptides
03/29/2007DE102005045671A1 Verwendung eines Kollagens xenogenen Ursprungs Use of a collagen xenogenic origin
03/29/2007DE10125882B4 Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus Medicament comprising ambroxol, its salts and / or prodrugs together with α-lipoic acid in the context of the treatment of diabetes mellitus
03/29/2007CA2663584A1 Composition and method for treating iron deficiency anemia
03/29/2007CA2663412A1 Compositions and methods for the augmentation and repair of defects in tissue
03/29/2007CA2644089A1 Protein kinase c peptide modulators of angiogenesis
03/29/2007CA2623772A1 Modulation of glucocorticoid receptor expression
03/29/2007CA2623529A1 Pdgf amphiphilic polymer complex
03/29/2007CA2623351A1 Antiviral therapy with carbohydrate binding agents
03/29/2007CA2623176A1 Protein a production and purification without using animal derived components
03/29/2007CA2623106A1 Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
03/29/2007CA2622987A1 Method of treating pulmonary disease with interferons
03/29/2007CA2622911A1 Methods for reducing cd36 expression
03/28/2007EP1767650A1 Method of screening compound directly activating glycogen synthase
03/28/2007EP1767642A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
03/28/2007EP1767641A1 Antigenic neisserial peptides
03/28/2007EP1767638A2 Mutation associated with epilepsy
03/28/2007EP1767637A1 Mutation associated with epilepsy
03/28/2007EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
03/28/2007EP1767634A1 Novel galectin 8 modification protein and use thereof
03/28/2007EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor
03/28/2007EP1767626A1 Peroral vaccine carrier system
03/28/2007EP1767546A1 Angiogenesis-inhibiting chimeric protein and the use
03/28/2007EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
03/28/2007EP1767543A1 Novel bee venom polypeptides and methods of use thereof
03/28/2007EP1767542A2 HLA-A2. 1 binding peptides and their uses
03/28/2007EP1767213A2 Method for improving stability of a bone-connecting implant
03/28/2007EP1767196A2 Highly efficient delivery of a large therapeutic mass aerosol
03/28/2007EP1767195A2 Stable spray-dried protein formulations
03/28/2007EP1767193A2 Pharmaceutical compositions
03/28/2007EP1766768A2 Use of lacritin in promoting ocular cell survival
03/28/2007EP1766091A2 Biomarkers for monitoring inhibition of impdh pathway
03/28/2007EP1766077A2 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
03/28/2007EP1766068A2 Egfr mutations
03/28/2007EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1)
03/28/2007EP1766033A2 Genetically modified non-human mammals and cells
03/28/2007EP1766024A1 Proteins with attached short peptide of acidic amino acids
1 ... 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 ... 3163